Related Experiment Video
Updated: Jul 20, 2025
09:01
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.1K
HOTAIR in colorectal cancer: structure, function, and therapeutic potential
1Institute of Biomedical Sciences, Shanxi University, Taiyuan, 030006, China. mtufail0276@gmail.com.
Medical Oncology (Northwood, London, England)
|August 2, 2023
Summary
The long non-coding RNA HOTAIR is upregulated in colorectal cancer (CRC), promoting tumor growth and treatment resistance. Understanding HOTAIR
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are crucial regulators of gene expression in cancer.
- The lncRNA HOTAIR is implicated in various cellular processes and cancer development.
- HOTAIR overexpression is linked to poor prognosis and chemoresistance in colorectal cancer (CRC).
Purpose of the Study:
- To elucidate the structure, functions, and mechanisms of HOTAIR in colorectal cancer.
- To explore HOTAIR's role in gene regulation and treatment resistance in CRC.
- To identify HOTAIR as a potential therapeutic target for colorectal cancer.
Main Methods:
- Review of existing literature on HOTAIR in CRC.
- Analysis of HOTAIR's molecular structure and domain interactions.
- Investigation of HOTAIR's regulatory interactions with miRNAs and protein complexes.
Main Results:
- HOTAIR expression is significantly upregulated in CRC tissues.
- HOTAIR promotes CRC progression through chromatin remodeling and gene silencing.
- HOTAIR interacts with specific microRNAs (miRNAs) to modulate gene expression.
- HOTAIR contributes to chemoresistance in colorectal cancer.
Conclusions:
- HOTAIR is a key oncogenic lncRNA in colorectal cancer.
- Targeting HOTAIR presents a promising therapeutic strategy for CRC.
- Further research is needed to fully understand HOTAIR's mechanisms in CRC and drug resistance.
Related Concept Videos
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K